Skip to content
CCL Products logo

CCL Products (India)

CCL NSE
₹964.40 +22.75 (+2.42%)
P/E
27.89
View as Markdown
MCP
Close 4 Nov 2026 ₹964.40 −8.70 −0.89% 1Y
Start ₹973.10

Key Fundamentals

MicrocapConsumer GoodsFMCG

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
15.80%
Debt to Equity
0.46
EPS (TTM)
₹34.58
Book Value
₹199.46
Market Cap
—
P/E (TTM)
27.89
P/B
4.84
ROE
18.00%
Dividend Yield
0.61%
EBITDA
₹741 Cr
52W High
₹1,242.20
52W Low
₹885.70
Day Range
₹938.80 – ₹966.20
Volume
89,073

Peer Comparison

Fast Moving Consumer Goods › Consumer Goods › Tea & Coffee

CCL Products peer comparison
Tata Consumer Products
₹1,068.0064.61₹1,06,600 Cr4.780.93%7.35%9.24%₹20,860 Cr₹1,643 Cr
CCL Products (this company)
₹964.4027.89₹12,745 Cr4.840.61%18.00%15.80%₹4,686 Cr₹462 Cr
Vintage Coffee & Beverages
₹168.7331.19₹2,267 Cr4.450.10%16.60%18.20%₹612 Cr₹79 Cr
Andrew Yule
₹24.47—₹1,178 Cr3.680.04%−24.00%−16.20%₹298 Cr−₹42 Cr
Goodricke Group
₹218.957.48₹484 Cr1.560.90%6.31%5.11%₹838 Cr₹64 Cr
McLeod Russel
₹44.08—₹460 Cr—0.00%—−4.56%₹1,200 Cr−₹93 Cr
The Peria Karamalai Tea & Produce
₹650.50—₹209 Cr0.450.11%−3.43%−0.26%₹61 Cr−₹5 Cr
Median 7 companies₹218.9529.54₹1,178 Cr4.070.11%6.83%5.11%₹838 Cr₹64 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

58 Good

Data confidence 100/100

Category scores

Quality
82
Strong
Returns, margins, earnings quality 22% weight
Valuation
41
Weak
Cheap vs sector & own history 24% weight
Growth
75
Strong
Sales & profit trajectory 9% weight
Financial Health
55
Average
Solvency, leverage, coverage 9% weight
Momentum
35
Poor
Trend strength, vol-adjusted 12% weight
Ownership
55
Good
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company has reduced debt.
  • Company has been maintaining a healthy dividend payout of 21.8%

Weaknesses

1
  • Stock is trading at 4.55 times its book value

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish964
OscillatorsBullish162
Moving AveragesStrong Bearish802

Key readings

RSI (14)
43.97
Neutral
MACD (12,26,9)
−32.67
Bullish
SMA (50)
1,038.70
Bearish
SMA (200)
1,078.34
Bearish

As of

Analyst Rating

Based on 10 analysts
BUY80%

8 of 10 analysts rate Buy, 2 Hold, 0 Sell.

As of

BUY
8
80%
HOLD
2
20%
SELL
0
0%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
10Y+16.94%
5Y+29.12%
3Y+29.11%
1Y+43.50%
TTM+24.07%

Net profit

Net profit growth by window
10Y+12.27%
5Y+16.35%
3Y+10.96%
1Y+25.16%
TTM+36.69%

Operating cash flow

Operating cash flow growth by window
10Y+18.21%
5Y+38.07%
3Y+70.54%
1Y+195.86%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−5.53 pp
5Y−7.52 pp
3Y−2.84 pp
1Y−1.40 pp
TTM−0.31 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹976 Cr
Mar 2018₹1,138 Cr
Mar 2019₹1,081 Cr
Mar 2020₹1,139 Cr
Mar 2021₹1,242 Cr
Mar 2022₹1,462 Cr
Mar 2023₹2,071 Cr
Mar 2024₹2,654 Cr
Mar 2025₹3,106 Cr
Mar 2026₹4,457 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹135 Cr
Mar 2018₹148 Cr
Mar 2019₹155 Cr
Mar 2020₹166 Cr
Mar 2021₹182 Cr
Mar 2022₹204 Cr
Mar 2023₹284 Cr
Mar 2024₹250 Cr
Mar 2025₹310 Cr
Mar 2026₹388 Cr

Analyst Forecasts

Forecast For
Dec 26 consensus · EBITDA
₹218 Cr +0.3% vs Sep 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 9 Oct 2026
AI opinion · based on fundamentals
Risk medium

As of the 2026-10-09 close, CCL Products (India) Ltd traded at ₹1,051.5, giving it a market capitalisation of ₹14,040.46 crore. It was valued at 32.46x trailing earnings (TTM EPS ₹32.39) and 5.99x book value. Sales grew 36% and profit grew 39% over the trailing twelve months. However, 3-year profit growth of 11% is well below 3-year sales growth of 29%. ROE is 16.55%, ROCE is 20.75% and debt-to-equity is 0.56. On 2026-10-09 the stock was about 15.4% below its 52-week high of ₹1,242.2 and about 28.8% above its 52-week low of ₹816.25.

Bull Case 8
  • Revenue growth is strong and steady. Sales compounded at 29% over both 3 and 5 years and 36% on a TTM basis, compared with 17% over 10 years. That suggests growth has sped up in recent years.
  • Profit growth has picked up recently. TTM profit growth of 39% is higher than TTM sales growth of 36%, which may mean operating leverage or margins are starting to recover after a period of compression.
  • Capital efficiency is solid. ROCE was 20.75% and ROE was 16.55% as of 2026-10-09. ROE has stayed around 17-18% over the last 1, 3, 5 and 10 years, so returns have held up through different cycles.
  • Leverage is moderate at a debt-to-equity ratio of 0.56, and the company has reduced its debt. This leaves room on the balance sheet to fund capacity expansion without heavy financial risk.
  • The stock has compounded over the long term: 16% CAGR over 10 years, 21% over 5 years, 18% over 3 years and 24% over the past year.
  • The company has kept a dividend payout ratio of 21.8%. That means it returns cash to shareholders while still keeping most of its earnings to fund growth.
  • At ₹1,051.5 on 2026-10-09, the stock was about 15.4% below its 52-week high of ₹1,242.2. The P/E of 32.46x is based on TTM earnings that grew 39%.
  • The company is expected to report a good quarter. Continued earnings momentum on top of TTM profit growth of 39% could support the case that recent growth is sustainable.
Bear Case 7
  • Profit growth has lagged sales growth over longer periods. Over 3 years profit compounded at 11% against 29% for sales, and over 5 years it was 16% against 29%. This points to margin compression, and part of the revenue growth may reflect higher input costs being passed through rather than a better volume or product mix.
  • The valuation is demanding. As of 2026-10-09 the stock traded at 5.99x book value and 32.46x TTM earnings, an earnings yield of about 3.1%. That leaves little room for error if growth slows.
  • Over 10 years, profit compounded at 12% while the stock compounded at 16%. Much of the stock's return has come from the valuation multiple expanding rather than from earnings growth alone.
  • ROE has slipped to 16.55%, below its 5-year and 10-year average of 18%. This could mean recent capital spending has not yet earned returns in line with past levels.
  • Debt-to-equity of 0.56 is still notable for a consumer goods business, even though the company has reduced debt. Higher working capital needs or further capacity spending could push leverage back up.
  • The dividend yield is low at 0.55% as of 2026-10-09, and the payout ratio is 21.8%. Income-focused investors get limited cash returns at this valuation.
  • The stock has been volatile. Its 52-week range of ₹816.25 to ₹1,242.2 is about a 52% spread from low to high, and at ₹1,051.5 on 2026-10-09 it was still about 28.8% above the low.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

28d ago

TL;DR: The only news in this set is the 65th AGM on September 8, 2026. Shareholders approved a ₹3.00 per share final dividend for FY26 and re-elected two directors with near-universal participation, which points to a steady payout and stable governance. These are routine items, not new information about operations, and no headwinds were reported in the articles provided. Coffee prices, export demand and earnings will matter more for the stock's direction in the coming quarters.

Positives 1
  • ₹3.00 final dividend approved Sep 8

    At the 65th AGM on September 8, 2026, shareholders approved a final dividend of ₹3.00 per share for FY26.

Neutral 1
  • Two retiring directors re-elected Sep 8

    Shareholders re-elected two retiring directors at the 65th AGM on September 8, 2026, with near-universal voting participation. This keeps the board as it was and signals strong shareholder engagement.

Quarterly Results

₹ Cr
CCL quarterly results, ₹ crore
Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
608
664
727
773
738
758
836
1,056
1,127
1,051
1,224
1,200
1,211
Expenses
498
554
609
643
601
634
673
897
930
866
1,033
1,007
999
Operating Profit
110
111
118
130
137
124
163
159
197
185
192
194
212
OPM %
18%
17%
16%
17%
19%
16%
20%
15%
18%
18%
16%
16%
18%
Other Income
1
1
4
1
1
3
4
2
1
3
2
3
5
Interest
18
23
21
21
27
31
34
34
33
32
30
29
26
Depreciation
23
22
31
23
24
25
27
34
39
39
40
39
40
PBT
70
67
70
87
87
72
106
94
127
116
123
129
151
Tax %
13%
5%
7%
18%
15%
12%
4%
23%
21%
14%
7%
9%
14%
Net Profit
61
63
65
71
74
63
102
72
101
100
115
117
130
EPS (₹)
4.57
4.76
4.88
5.35
5.54
4.72
7.63
5.43
7.55
7.51
8.58
8.75
9.74

Profit & Loss

₹ Cr
CCL profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
881
932
976
1,138
1,081
1,139
1,242
1,462
2,071
2,654
3,106
4,457
4,686
Expenses
709
727
744
899
836
853
945
1,131
1,671
2,208
2,551
3,723
3,904
Operating Profit
171
205
232
239
245
286
298
331
400
445
555
734
782
OPM %
19%
22%
24%
21%
23%
25%
24%
23%
19%
17%
18%
16%
17%
Other Income
3
1
1
5
3
4
3
4
3
6
8
8.43
13
Interest
14
11
11
8
8
18
17
16
34
78
113
129
117
Depreciation
27
28
33
34
32
47
49
57
64
98
98
152
159
PBT
134
167
189
202
209
225
235
261
305
276
352
461
519
Tax %
30%
27%
29%
27%
26%
26%
22%
22%
7%
9%
12%
16%
—
Net Profit
94
122
135
148
155
166
182
204
284
250
310
388
462
EPS (₹)
7.06
9.18
10.12
11.14
11.64
12.47
13.7
15.36
21.35
18.73
23.24
29.07
34.58
Div. Payout %
21%
27%
25%
22%
30%
40%
29%
33%
26%
24%
22%
20%
—

Balance Sheet

₹ Cr
CCL balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
27
27
27
27
27
27
27
27
27
27
27
27
27
Reserves
395
483
602
713
812
902
1,061
1,224
1,471
1,647
1,941
2,318
2,637
Borrowings
229
210
142
311
416
469
559
655
920
1,622
1,815
1,324
1,226
Other Liabilities
111
81
78
83
166
112
142
164
180
240
459
657
592
Total Liabilities
762
801
848
1,134
1,422
1,509
1,788
2,070
2,597
3,536
4,241
4,326
4,482
Fixed Assets
340
417
393
371
383
724
798
882
1,257
1,252
1,622
2,027
2,022
CWIP
53
0
0
226
424
100
149
160
54
501
450
3
5
Investments
2
2
2
1
1
1
0
0
0
0
0
3
3
Other Assets
367
382
453
535
613
684
841
1,028
1,286
1,783
2,169
2,293
2,452
Total Assets
762
801
848
1,134
1,422
1,509
1,788
2,070
2,597
3,536
4,241
4,326
4,482

Cash Flow

₹ Cr
CCL cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
105
161
102
145
162
91
171
116
173
55
290
858
Investing
−19
−87
−20
−247
−175
−88
−153
−192
−307
−527
−415
18
Financing
−93
−82
−84
129
42
−37
64
9
164
559
53
−757
Net Cash Flow
−8
−8
−2
27
29
−35
82
−67
30
86
−72
120
Free Cash Flow
84
74
84
−78
−80
2
16
−74
−159
−458
−128
788
CFO/EBITDA
86
97
67
84
89
50
66
47
52
19
57
123

Ratios

CCL financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
47
50
61
58
79
86
88
80
78
68
81
67
Inventory Days
116
99
121
97
123
170
198
262
187
185
208
131
Days Payable
29
8
8
5
35
16
13
23
24
23
44
32
Cash Conversion Cycle
134
142
174
150
168
240
272
319
241
230
246
166
Working Capital Days
45
37
81
89
43
103
59
77
58
40
42
41
ROCE %
23%
26%
27%
23%
19%
18%
17%
16%
16%
12%
13%
16%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view CCL Products insights

61 extracted metrics across FY08–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 46.16%
  • DIIs 21.41%
  • FIIs 12.12%
  • Others 10.74%
  • Public 9.57%

No promoter shares pledged as of Sep 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about CCL Products (India)

What does CCL Products (India) Ltd do?
CCL Products (India) is engaged in the production, trading and distribution of Coffee. The Company has business operations mainly in India, Vietnam and Switzerland countries.
Where is CCL Products (India) Ltd (CCL) listed?
CCL Products (India) Ltd trades as CCL on the NSE and under code 519600 on the BSE.
Which sector does CCL Products (India) Ltd belong to?
CCL Products (India) Ltd is classified under the Consumer Goods sector, in the Tea & Coffee industry.
What is the PE ratio of CCL Products (India) Ltd?
CCL Products (India) Ltd trades at a PE ratio of 27.89 as of 4 Nov 2026, on earnings per share of ₹34.58, against a book value of ₹199.46 per share.
What is the 52-week high and low of CCL Products (India) Ltd?
Over the last 52 weeks CCL Products (India) Ltd has traded between ₹885.7 and ₹1,242.2 as of 4 Nov 2026.
Does CCL Products (India) Ltd pay dividends?
CCL Products (India) Ltd has a dividend yield of 0.61%.
What is the Return on Equity (ROE) of CCL Products (India) Ltd?
CCL Products (India) Ltd reported a return on equity of 18.00%. Its debt-to-equity ratio is 0.46.

Company Information

CCL Products (India) is engaged in the production, trading and distribution of Coffee. The Company has business operations mainly in India, Vietnam and Switzerland countries.

Website cclproducts.com
CEO Mr. Challa Rajendra Prasad B.E
Employees 1,358
Listed 7 Jun 2004
Face Value ₹2

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CCL.md for CCL Products (India) Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Agri & Food Products stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month